SCHEMBL7790973

SCHEMBL7790973

COc1cc2cnc(Nc3cccc(O)c3O)nc2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 9/20 0.57
KIF5B P33176 5/20 0.57
KDR P35968 4/20 0.57
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
FGFR1 P11362 5/20 0.42
WEE1 P30291 1/20 0.41
FGFR4 P22455 3/20 0.41
FGFR2 P21802 2/20 0.41
FGFR3 P22607 2/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1539121 0.90 RET (0.55) RETKIF5BKDRKDM4EALDH1A1
SCHEMBL7799232 0.81 CSF1R (0.49) KDM4EALDH1A1SMN1; SMN2FGFR1RAB9A
SCHEMBL7799235 0.80 CSF1R (0.52) RETKIF5BKDRKDM4EALDH1A1
SCHEMBL7799373 0.80 EGFR (0.44) RETKIF5BKDRKDM4EALDH1A1
SCHEMBL7791030 0.80 FLT1 (0.55) KDRKDM4EALDH1A1SMN1; SMN2FGFR1
SCHEMBL7790969 0.80 EGFR (0.55) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR4
SCHEMBL7800417 0.80 LRRK2 (0.53) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR4
SCHEMBL7791014 0.80 C1R (0.51) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR4
SCHEMBL7753469 0.79 FGFR1 (0.56) RETKIF5BKDRFGFR1TP53
SCHEMBL7800394 0.78 AURKA (0.53) KDM4EFGFR1FGFR4FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed